Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Jan 25.
Published in final edited form as: Nat Neurosci. 2022 Jan;25(1):127. doi: 10.1038/s41593-021-00994-3

Retraction Note: Tumor necrosis factor overcomes immune evasion in p53-mutant medulloblastoma

Alexandra Garancher, Hiromichi Suzuki, Svasti Haricharan, Lianne Q Chau, Meher Beigi Masihi, Jessica M Rusert, Paula S Norris, Florent Carrette, Megan M Romero, Sorana A Morrissy, Patryk Skowron, Florence M G Cavalli, Hamza Farooq, Vijay Ramaswamy, Steven J M Jones, Richard A Moore, Andrew J Mungall, Yussanne Ma, Nina Thiessen, Yisu Li, Alaide Morcavallo, Lin Qi, Mari Kogiso, Yuchen Du, Patricia Baxter, Jacob J Henderson, John R Crawford, Michael L Levy, James M Olson, Yoon-Jae Cho, Aniruddha J Deshpande, Xiao-Nan Li, Louis Chesler, Marco A Marra, Harald Wajant, Oren J Becher, Linda M Bradley, Carl F Ware, Michael D Taylor, Robert J Wechsler-Reya
PMCID: PMC8787865  NIHMSID: NIHMS1772318  PMID: 34907396

The authors are retracting this paper owing to issues with the integrity of the data presented. Specifically, inconsistencies in the flow cytometry data in Figs. 2d, 4b, 5c,d, 5g,h, 6a,b and 7a–d, and Extended Data Figs. 2b, 3a–i, and 6c–j were found, with selected experimental samples collected using different settings from their corresponding controls. Thus, the data in these figures do not reflect the true fluorescence of the samples in question. In addition, we have been unable to replicate the key in vivo findings in the paper, including those presented in Fig. 7e–h and Extended Data Fig. 8d–k. These concerns undermine our confidence in the study and we therefore wish to retract the article in its entirety. We deeply regret this incident and apologize to the scientific community.

RESOURCES